You have 9 free searches left this month | for more free features.

non-myeloablative

Showing 26 - 50 of >10,000

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Acute Leukemia, Hematologic and Lymphocytic Disorder, Myelodysplastic Syndrome Trial in Duarte (Fludarabine, Itacitinib Adipate,

Active, not recruiting
  • Acute Leukemia
  • +4 more
  • Duarte, California
    City of Hope Medical Center
Jan 4, 2023

Single Umbilical Cord Blood Transplantation, Non-myeloablative Conditioning, Acute Lymphocytic Leukemia Trial in Minneapolis

Completed
  • Single Umbilical Cord Blood Transplantation
  • +6 more
  • Minneapolis, Minnesota
    Novartis Investigative Site
Dec 9, 2020

Epithelial Tumors, Malignant, Malignant Solid Tumor Trial in Barcelona (NEXTGEN-TIL, Non-myeloablative Lymphodepletion (NMA-LD)

Recruiting
  • Epithelial Tumors, Malignant
  • Malignant Solid Tumor
  • NEXTGEN-TIL
  • +2 more
  • Barcelona, Spain
    Vall d'Hebron Institute of Oncology
Nov 25, 2021

Acute Leukemia, Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia Trial in Minneapolis (HSCT with TBI Regimen, HSCT with

Recruiting
  • Acute Leukemia
  • +27 more
  • HSCT with TBI Regimen
  • HSCT with Non-TBI Regimen
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Apr 12, 2022

Leukemia, Lymphoma, Non-Hodgkin, Hematologic Diseases Trial in Stanford (Sirolimus, MMF, BCNU)

Completed
  • Leukemia
  • +3 more
  • Stanford, California
    Stanford University School of Medicine
Sep 16, 2021

Myeloproliferative Disorders, Leukemia, Lymphoma Trial in Minneapolis (biological, drug, procedure, radiation)

Completed
  • Myeloproliferative Disorders
  • +3 more
  • anti-thymocyte globulin
  • +6 more
  • Minneapolis, Minnesota
    Masonic Cancer Center at University of Minnesota
Oct 30, 2020

Metastatic Melanoma Trial in Los Angeles (F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells, non-myeloablative

Completed
  • Metastatic Melanoma
  • F5 TCR transgenic cells and MART-1 peptide pulsed dendritic cells
  • non-myeloablative conditioning chemotherapy
  • Los Angeles, California
    University of California Los Angeles, David Geffen School of Med
Dec 3, 2021

Recurrent Severe Aplastic Anemia, Refractory Severe Aplastic Anemia Trial in Duarte (biological, procedure, drug, other)

Not yet recruiting
  • Recurrent Severe Aplastic Anemia
  • Refractory Severe Aplastic Anemia
  • Anti-Thymocyte Globulin
  • +7 more
  • Duarte, California
    City of Hope Medical Center
Feb 23, 2023

Multiple Myeloma Trial in Worldwide (HLA Matched allogeneic transplant)

Completed
  • Multiple Myeloma
  • HLA Matched allogeneic transplant
  • Wien, Austria
  • +23 more
Oct 5, 2021

Stiff-Person Syndrome Trial in Chicago (Autologous Hematopoietic Stem Cells, Cyclophosphamide, Mesna)

Terminated
  • Stiff-Person Syndrome
  • Autologous Hematopoietic Stem Cells
  • +6 more
  • Chicago, Illinois
    Northwestern University
Jan 6, 2021

Hematologic Malignancies Trial in Lebanon (Stem Cell Transplant, G-CSF, Fludarabine)

Completed
  • Hematologic Malignancies
  • Stem Cell Transplant
  • +5 more
  • Lebanon, New Hampshire
    Dartmouth-Hitchcock Medical Center
Oct 30, 2020

AML, MDS Trial in Belgium, United States (NKR-2)

Completed
  • AML
  • MDS
  • NKR-2
  • Aurora, Colorado
  • +6 more
Apr 30, 2021

HEMATOLOGIC MALIGNANCIES Trial in Torino (TOTAL LYMPHOID IRRADIATION)

Active, not recruiting
  • HEMATOLOGIC MALIGNANCIES
  • TOTAL LYMPHOID IRRADIATION
  • Torino, Italy
    A.O.U. San Giovanni Battista
Feb 2, 2021

B-Cell Non-Hodgkin Lymphoma, DLBCL, Mantle Cell Lymphoma Trial in Duarte (Anti-CD19-CAR CMV-specific T-lymphocytes, Autologous

Not yet recruiting
  • B-Cell Non-Hodgkin Lymphoma
  • +7 more
  • Anti-CD19-CAR CMV-specific T-lymphocytes
  • +3 more
  • Duarte, California
    City of Hope Medical Center
Jun 28, 2022

Multiple Myeloma Trial in United States (procedure, drug, behavioral)

Completed
  • Multiple Myeloma
  • One Autologous Transplant
  • +5 more
  • Birmingham, Alabama
  • +35 more
Oct 19, 2021

B-cell Lymphoma, Burkitt Lymphoma, Diffuse Large B Cell Lymphoma Trial in Valhalla (Polatuzumab vedotin)

Recruiting
  • B-cell Lymphoma
  • +8 more
  • Polatuzumab vedotin
  • Valhalla, New York
    New York Medical Center
Oct 29, 2021

Lymphoma, Non-Hodgkin Trial in United States (Hematopoietic Stem Cell Transplant)

Completed
  • Lymphoma, Non-Hodgkin
  • Hematopoietic Stem Cell Transplant
  • Duarte, California
  • +20 more
Dec 7, 2021

Myeloid Leukemia, Chronic, Acute Myelogenous Leukemia, MDS (MDS) Trial in Palo Alto (Conventional T cells (Tcon) and Regulatory

Recruiting
  • Myeloid Leukemia, Chronic
  • +8 more
  • Conventional T cells (Tcon) and Regulatory T cells (Treg)
  • Palo Alto, California
    Stanford University School of Medicine Palo Alto, California, Un
Aug 18, 2021

Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in United States (Preparative Regimen, NK Cells, Interleukin-2)

Completed
  • Acute Myeloid Leukemia
  • Myelodysplastic Syndrome
  • Preparative Regimen
  • +4 more
  • Atlanta, Georgia
  • +3 more
Apr 29, 2020

Leukemia, Lymphoma, MDS Trial (biological, drug, procedure)

Withdrawn
  • Leukemia
  • +2 more
  • filgrastim
  • +4 more
  • (no location specified)
Jul 29, 2020

Relapse/Refractory Multiple Myeloma Trial in Belgium, United States (CYAD-211, Endoxan, Fludara)

Recruiting
  • Relapse/Refractory Multiple Myeloma
  • CYAD-211
  • +2 more
  • Tampa, Florida
  • +4 more
Nov 26, 2020

Chronic Inflammatory Demyelinating Polyneuropathy Trial in Chicago (hematopoietic stem cell transplantation)

Completed
  • Chronic Inflammatory Demyelinating Polyneuropathy
  • hematopoietic stem cell transplantation
  • Chicago, Illinois
    Northwestern University, Feinberg School of Medicine
Jul 15, 2020

Acute Biphenotypic Leukemia, Acute Erythroid Leukemia in Remission, Acute Leukemia in Remission Trial in Seattle (drug,

Terminated
  • Acute Biphenotypic Leukemia
  • +29 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Jan 4, 2023

Scleroderma, Systemic Trial in Chicago (Peripheral Blood Stem Cells, Cyclophosphamide, Mesna)

Terminated
  • Scleroderma, Systemic
  • Peripheral Blood Stem Cells
  • +6 more
  • Chicago, Illinois
    Northwestern University
Jul 7, 2020

Lymphoma, Non-Hodgkin's, Adult, Lymphoma, Hodgkin's, Adult Trial (FE 203799)

Withdrawn
  • Lymphoma, Non-Hodgkin's, Adult
  • Lymphoma, Hodgkin's, Adult
  • FE 203799
  • (no location specified)
Oct 22, 2020